(DAUNORUBICIN AND CYTARABINE) LIPOSOME

(DAUNORUBICIN AND CYTARABINE) LIPOSOME was reported 2431 times

(DAUNORUBICIN AND CYTARABINE) LIPOSOME is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEUROLEUKAEMIOSIS 2 0.5000
1 CYTARABINE SYNDROME 32 0.4211
2 CLOSTRIDIUM TEST 11 0.3548
3 DELAYED HAEMATOPOIETIC RECONSTITUTION 2 0.2222
4 ACUTE POST ASTHMATIC AMYOTROPHY 1 0.1667
5 CATHETER SITE ECZEMA 1 0.1429
6 CORYNEBACTERIUM BACTERAEMIA 11 0.1294
7 BONE MARROW HAEMORRHAGE 1 0.1250
8 ANTI-HLA ANTIBODY TEST POSITIVE 2 0.1176
9 ACUTE MYELOID LEUKAEMIA REFRACTORY 15 0.0872
10 POSITIVE END-EXPIRATORY PRESSURE 1 0.0833
11 ACUTE MYELOID LEUKAEMIA RECURRENT 177 0.0824
12 URTICARIA VESICULOSA 3 0.0789
13 CEREBELLAR EMBOLISM 2 0.0690
14 SEPTAL PANNICULITIS 5 0.0625
15 MYELOBLAST PERCENTAGE INCREASED 1 0.0476
16 CORYNEBACTERIUM SEPSIS 3 0.0455
17 LEUKAEMIC INFILTRATION PULMONARY 2 0.0435
18 BLAST CELLS PRESENT 20 0.0416
19 BLAST CELL COUNT INCREASED 41 0.0391
20 MYELOBLAST COUNT INCREASED 3 0.0390
21 TONGUE EROSION 1 0.0385
22 STENOTROPHOMONAS TEST POSITIVE 5 0.0373
23 ABNORMAL PRECORDIAL MOVEMENT 1 0.0370
24 ACUTE ERYTHROID LEUKAEMIA 2 0.0317
25 PARVOVIRUS B19 INFECTION REACTIVATION 1 0.0312
26 STENOTROPHOMONAS MALTOPHILIA PNEUMONIA 2 0.0290
27 HEPATOSPLENIC CANDIDIASIS 4 0.0272
28 ELECTROCARDIOGRAM LOW VOLTAGE 2 0.0263
29 DISSEMINATED VARICELLA 1 0.0263
30 STENOTROPHOMONAS BACTERAEMIA 2 0.0263
31 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 4 0.0231
32 BLOOD COPPER INCREASED 4 0.0225
33 SEPTIC PULMONARY EMBOLISM 4 0.0205
34 ACUTE MYELOID LEUKAEMIA 313 0.0201
35 CONGENITAL APLASIA 6 0.0193
36 REFRACTORINESS TO PLATELET TRANSFUSION 2 0.0183
37 PULMONARY HAEMATOMA 2 0.0171
38 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 11 0.0168
39 STENOTROPHOMONAS SEPSIS 2 0.0165
40 HERPES SIMPLEX VIRAEMIA 2 0.0160
41 OVARIAN NECROSIS 1 0.0159
42 ACANTHOLYSIS 1 0.0152
43 FIBRINOLYSIS 1 0.0147
44 HEPATIC CANDIDIASIS 1 0.0147
45 TRANSPLANTATION COMPLICATION 6 0.0143
46 HUMAN HERPESVIRUS 6 ENCEPHALITIS 4 0.0141
47 MYRINGITIS 1 0.0135
48 ENTEROBACTER BACTERAEMIA 4 0.0132
49 PRE-ENGRAFTMENT IMMUNE REACTION 1 0.0125
50 RED BLOOD CELL TRANSFUSION 5 0.0122
51 SCLERAL OEDEMA 1 0.0120
52 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 3 0.0118
53 TOXIC ERYTHEMA OF CHEMOTHERAPY 3 0.0116
54 ANTI-PLATELET ANTIBODY POSITIVE 2 0.0116
55 OSTEORRHAGIA 1 0.0114
56 INFECTIVE THROMBOSIS 1 0.0112
57 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 10 0.0108
58 VITAMIN C DEFICIENCY 2 0.0103
59 NASAL HERPES 2 0.0099
60 THROMBOPHLEBITIS SEPTIC 2 0.0098
61 IMMOBILISATION SYNDROME 2 0.0094
62 BACILLUS BACTERAEMIA 1 0.0092
63 SUBDIAPHRAGMATIC ABSCESS 1 0.0089
64 MUCOUS MEMBRANE PEMPHIGOID 1 0.0088
65 FUSARIUM INFECTION 6 0.0086
66 HUMAN METAPNEUMOVIRUS TEST POSITIVE 1 0.0085
67 DERMO-HYPODERMITIS 5 0.0084
68 ROSEOLOVIRUS TEST POSITIVE 1 0.0082
69 DERMATOSIS 5 0.0080
70 FEBRILE NEUTROPENIA 528 0.0080
71 ANAL INFECTION 2 0.0078
72 NEUTROPENIC COLITIS 16 0.0077
73 APLASIA 15 0.0077
74 CENTRAL NERVOUS SYSTEM LEUKAEMIA 3 0.0076
75 ENTEROCOCCAL BACTERAEMIA 8 0.0075
76 ASPIRATION BONE MARROW 1 0.0075
77 TUMOUR ASSOCIATED FEVER 3 0.0073
78 ATYPICAL MYCOBACTERIAL PNEUMONIA 1 0.0072
79 URETERITIS 2 0.0071
80 LEUKAEMIC INFILTRATION 1 0.0071
81 CHLOROMA 3 0.0071
82 OROPHARYNGEAL OEDEMA 1 0.0069
83 ANAL FISTULA INFECTION 1 0.0067
84 CYTOPENIA 81 0.0066
85 FEBRILE BONE MARROW APLASIA 28 0.0066
86 RASH FOLLICULAR 1 0.0065
87 LEUKAEMIA CUTIS 1 0.0065
88 PNEUMONIA CHLAMYDIAL 1 0.0064
89 PNEUMONIA FUNGAL 25 0.0063
90 ALLOGENIC STEM CELL TRANSPLANTATION 1 0.0063
91 STENOTROPHOMONAS INFECTION 8 0.0059
92 CATHETER SITE ABSCESS 1 0.0057
93 KLEBSIELLA SEPSIS 6 0.0053
94 SCROTAL ABSCESS 2 0.0053
95 MENINGOCOCCAL SEPSIS 1 0.0053
96 STREPTOCOCCAL URINARY TRACT INFECTION 1 0.0052
97 BACTERAEMIA 58 0.0049
98 SEPTIC EMBOLUS 4 0.0048
99 BACILLUS INFECTION 3 0.0047
100 ACTIVITIES OF DAILY LIVING DECREASED 3 0.0047
101 STREPTOCOCCAL BACTERAEMIA 5 0.0046
102 GLOSSOPTOSIS 1 0.0046
103 ELECTROCARDIOGRAM T WAVE ABNORMAL 7 0.0045
104 INFUSION SITE PHLEBITIS 1 0.0044
105 PARENTERAL NUTRITION 1 0.0043
106 METABOLIC ENCEPHALOPATHY 13 0.0043
107 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0043
108 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 2 0.0043
109 PELVIC FLUID COLLECTION 3 0.0043
110 EXTRAVASATION BLOOD 1 0.0042
111 ACUTE PULMONARY OEDEMA 23 0.0041
112 PLATELET TRANSFUSION 5 0.0039
113 SCROTAL ULCER 1 0.0038
114 ESCHERICHIA BACTERAEMIA 9 0.0038
115 ENTEROCOLITIS 22 0.0038
116 RESPIRATORY MONILIASIS 1 0.0037
117 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 3 0.0037
118 STAPHYLOCOCCAL BACTERAEMIA 16 0.0037
119 ENTEROCOLITIS BACTERIAL 1 0.0036
120 GENITOURINARY TRACT INFECTION 1 0.0035
121 LEUKAEMIA RECURRENT 6 0.0035
122 PSEUDOMONAL BACTERAEMIA 3 0.0035
123 NEUTROPENIC SEPSIS 25 0.0035
124 CARDIO-RESPIRATORY DISTRESS 1 0.0035
125 ENGRAFT FAILURE 1 0.0035
126 PROCALCITONIN INCREASED 4 0.0034
127 TISSUE INFILTRATION 1 0.0034
128 IDIOPATHIC PNEUMONIA SYNDROME 1 0.0034
129 PNEUMONIA PSEUDOMONAL 5 0.0033
130 ASPERGILLUS TEST POSITIVE 1 0.0032
131 DEVICE RELATED BACTERAEMIA 1 0.0032
132 TUMOUR LYSIS SYNDROME 28 0.0032
133 DEFECT CONDUCTION INTRAVENTRICULAR 1 0.0031
134 CELLULITE 1 0.0031
135 FASCIITIS 2 0.0030
136 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 217 0.0030
137 DEVICE RELATED THROMBOSIS 3 0.0030
138 VASCULAR DEVICE OCCLUSION 1 0.0029
139 THYMOMA 1 0.0028
140 GASTRIC MUCOSAL LESION 2 0.0027
141 PNEUMONIA KLEBSIELLA 5 0.0027
142 ESSENTIAL THROMBOCYTHAEMIA 1 0.0027
143 ENTEROBACTER SEPSIS 1 0.0027
144 LUMBAR PUNCTURE 1 0.0026
145 QRS AXIS ABNORMAL 2 0.0026
146 BONE MARROW FAILURE 52 0.0026
147 STREPTOCOCCAL SEPSIS 3 0.0025
148 ENTEROCOCCAL SEPSIS 2 0.0025
149 CEREBRAL ARTERY EMBOLISM 3 0.0025
150 PSEUDOMONAS TEST POSITIVE 2 0.0024
151 GASTROINTESTINAL ANGIODYSPLASIA 1 0.0024
152 CARDIAC DYSFUNCTION 9 0.0024
153 CARDITIS 1 0.0024
154 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 2 0.0024
155 CITROBACTER INFECTION 1 0.0023
156 ANAL SPHINCTER ATONY 1 0.0023
157 TOXIC SKIN ERUPTION 23 0.0023
158 PNEUMATOSIS 1 0.0022
159 EPSTEIN-BARR VIRUS INFECTION 14 0.0022
160 MENINGOENCEPHALITIS HERPETIC 1 0.0022
161 VENOOCCLUSIVE LIVER DISEASE 11 0.0022
162 BRONCHOPULMONARY ASPERGILLOSIS 17 0.0022
163 ACUTE GRAFT VERSUS HOST DISEASE 10 0.0022
164 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 5 0.0021
165 DEVICE RELATED INFECTION 33 0.0021
166 KLEBSIELLA BACTERAEMIA 2 0.0021
167 GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0021
168 ENCEPHALITIS HERPES 1 0.0020
169 MUCOSAL DISORDER 2 0.0020
170 BLOOD CULTURE POSITIVE 6 0.0020
171 PHARYNGEAL ABSCESS 1 0.0020
172 ERYTHEMA NODOSUM 7 0.0020
173 SEPSIS SYNDROME 1 0.0020
174 DRUG ERUPTION 35 0.0020
175 HERPES ZOSTER OTICUS 1 0.0020
176 MYELOSUPPRESSION 71 0.0020
177 STAPHYLOCOCCUS TEST POSITIVE 4 0.0019
178 PULMONARY MUCORMYCOSIS 1 0.0019
179 RESPIRATORY TRACT INFECTION FUNGAL 1 0.0019
180 PNEUMOCYSTIS JIROVECII PNEUMONIA 19 0.0019
181 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
182 PERIODONTITIS 4 0.0018
183 BACTERIAL SEPSIS 6 0.0018
184 EPIGLOTTITIS 1 0.0018
185 INTERTRIGO 1 0.0018
186 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4 0.0018
187 CLOSTRIDIUM TEST POSITIVE 4 0.0018
188 MUCOSAL INFLAMMATION 47 0.0018
189 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
190 CYTOGENETIC ABNORMALITY 2 0.0018
191 SEPTIC SHOCK 77 0.0018
192 BLOOD FIBRINOGEN DECREASED 2 0.0018
193 MEDIASTINITIS 1 0.0017
194 ESCHERICHIA SEPSIS 5 0.0017
195 APLASTIC ANAEMIA 9 0.0017
196 EJECTION FRACTION 1 0.0017
197 DOSE CALCULATION ERROR 1 0.0017
198 ENGRAFTMENT SYNDROME 1 0.0017
199 ESCHERICHIA TEST POSITIVE 2 0.0017
200 SACRAL PAIN 1 0.0016
201 MONOCYTE COUNT DECREASED 2 0.0016
202 MONOCYTOSIS 1 0.0016
203 BILIARY TRACT INFECTION 1 0.0016
204 EJECTION FRACTION DECREASED 25 0.0016
205 EPSTEIN-BARR VIRUS TEST POSITIVE 1 0.0016
206 BRAIN ABSCESS 4 0.0016
207 CONJUNCTIVAL HAEMORRHAGE 6 0.0016
208 VASCULAR DEVICE INFECTION 7 0.0015
209 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
210 HYPERLACTACIDAEMIA 4 0.0015
211 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
212 SIALOADENITIS 2 0.0015
213 MARROW HYPERPLASIA 1 0.0015
214 AORTITIS 1 0.0015
215 ANGULAR CHEILITIS 1 0.0014
216 GRANULOMATOUS LIVER DISEASE 1 0.0014
217 DISSEMINATED INTRAVASCULAR COAGULATION 20 0.0014
218 ACUTE RESPIRATORY DISTRESS SYNDROME 25 0.0014
219 ORGANISING PNEUMONIA 7 0.0014
220 SCROTAL OEDEMA 1 0.0014
221 NEUTROPHIL COUNT DECREASED 57 0.0014
222 PULMONARY SEPSIS 2 0.0014
223 SPONTANEOUS HAEMATOMA 1 0.0013
224 INFECTIOUS PLEURAL EFFUSION 2 0.0013
225 RASH MACULO-PAPULAR 29 0.0013
226 SEPSIS 142 0.0013
227 FUNGAEMIA 2 0.0013
228 PNEUMONIA VIRAL 4 0.0013
229 SINUSITIS FUNGAL 1 0.0012
230 PURPURA 11 0.0012
231 LIVER ABSCESS 4 0.0012
232 POLYCYTHAEMIA VERA 1 0.0012
233 ASPERGILLUS INFECTION 8 0.0012
234 BALANOPOSTHITIS 1 0.0012
235 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
236 DYSCHROMATOPSIA 1 0.0012
237 VENOOCCLUSIVE DISEASE 3 0.0012
238 PERITONSILLAR ABSCESS 1 0.0012
239 SYSTEMIC CANDIDA 3 0.0012
240 ENTEROBACTER INFECTION 2 0.0012
241 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
242 CRANIOFACIAL FRACTURE 1 0.0012
243 HEPATIC HAEMORRHAGE 1 0.0012
244 PSEUDOMONAL SEPSIS 2 0.0011
245 THROMBOPHLEBITIS 4 0.0011
246 ABDOMINAL SEPSIS 1 0.0011
247 PERICARDITIS 19 0.0011
248 CANDIDA SEPSIS 1 0.0011
249 LIQUID PRODUCT PHYSICAL ISSUE 8 0.0011
250 CARDIOMYOPATHY 16 0.0011
251 LUNG CONSOLIDATION 3 0.0011
252 MICROANGIOPATHY 1 0.0011
253 CATHETER SITE INFECTION 4 0.0011
254 ONCOLOGIC COMPLICATION 1 0.0010
255 PULMONARY HAEMORRHAGE 8 0.0010
256 MASTOIDITIS 1 0.0010
257 STAPHYLOCOCCAL SEPSIS 5 0.0010
258 HYPOFIBRINOGENAEMIA 1 0.0010
259 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
260 CYSTITIS HAEMORRHAGIC 4 0.0010
261 CRANIOCEREBRAL INJURY 3 0.0010
262 HEPATOCELLULAR INJURY 14 0.0010
263 ARTHRITIS BACTERIAL 4 0.0010
264 HAEMORRHOIDS 19 0.0010
265 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
266 SKIN INDURATION 2 0.0010
267 LYMPHANGIOSIS CARCINOMATOSA 1 0.0010
268 ORAL DISORDER 7 0.0010
269 CELLULITIS 48 0.0010
270 NON-CARDIOGENIC PULMONARY OEDEMA 1 0.0009
271 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 2 0.0009
272 CATHETER SITE ERYTHEMA 2 0.0009
273 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 7 0.0009
274 IDIOPATHIC URTICARIA 1 0.0009
275 ANAL ABSCESS 5 0.0009
276 BLADDER DILATATION 1 0.0009
277 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
278 EPSTEIN-BARR VIRAEMIA 1 0.0009
279 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
280 CEREBRAL HAEMORRHAGE 32 0.0009
281 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
282 IMMUNE THROMBOCYTOPENIA 4 0.0009
283 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
284 PALMAR ERYTHEMA 1 0.0009
285 PERIPHERAL EMBOLISM 1 0.0009
286 SPLENECTOMY 1 0.0009
287 SHOCK HAEMORRHAGIC 7 0.0009
288 SYSTEMIC MYCOSIS 1 0.0009
289 VOLVULUS 2 0.0008
290 LABILE BLOOD PRESSURE 1 0.0008
291 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
292 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
293 CARDIOGENIC SHOCK 12 0.0008
294 GRAFT VERSUS HOST DISEASE 6 0.0008
295 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
296 CARDIAC DEATH 1 0.0008
297 CLOSTRIDIUM COLITIS 1 0.0008
298 PHARYNGEAL INFLAMMATION 1 0.0008
299 HAEMATOLOGICAL INFECTION 2 0.0008
300 PHARYNGEAL HAEMORRHAGE 1 0.0008
301 MULTIPLE ORGAN DYSFUNCTION SYNDROME 23 0.0008
302 ACUTE PSYCHOSIS 2 0.0008
303 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
304 CATHETER SITE HAEMORRHAGE 2 0.0008
305 ERYSIPELAS 4 0.0008
306 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
307 TOXIC ENCEPHALOPATHY 4 0.0008
308 HEPATIC CYTOLYSIS 10 0.0008
309 NOCARDIOSIS 2 0.0008
310 INCREASED BRONCHIAL SECRETION 2 0.0008
311 FUNGAL INFECTION 26 0.0008
312 APHTHOUS ULCER 6 0.0008
313 TRANSITIONAL CELL CARCINOMA 1 0.0008
314 CATHETER SITE PAIN 2 0.0008
315 MUCORMYCOSIS 2 0.0008
316 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
317 LUNG OPACITY 2 0.0008
318 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
319 CARDIAC FAILURE ACUTE 5 0.0007
320 BACTERIAL INFECTION 14 0.0007
321 HAEMORRHAGE INTRACRANIAL 11 0.0007
322 BLOOD PHOSPHORUS INCREASED 2 0.0007
323 SUBDURAL HAEMORRHAGE 2 0.0007
324 FAECALOMA 4 0.0007
325 GENERALISED OEDEMA 9 0.0007
326 RHONCHI 1 0.0007
327 DIABETIC METABOLIC DECOMPENSATION 1 0.0007
328 LARGE INTESTINE PERFORATION 5 0.0007
329 THROMBOTIC MICROANGIOPATHY 7 0.0007
330 HYPERPYREXIA 3 0.0007
331 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
332 ALVEOLITIS 1 0.0007
333 NEUTROPHIL COUNT ABNORMAL 2 0.0007
334 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
335 INVESTIGATION ABNORMAL 1 0.0007
336 MYELODYSPLASTIC SYNDROME 10 0.0007
337 DYSPNOEA AT REST 2 0.0007
338 NODAL RHYTHM 1 0.0007
339 MOUTH HAEMORRHAGE 5 0.0007
340 PANCYTOPENIA 38 0.0007
341 DISEASE PROGRESSION 80 0.0007
342 ACUTE RESPIRATORY FAILURE 13 0.0007
343 INFUSION SITE REACTION 2 0.0007
344 MANTLE CELL LYMPHOMA 1 0.0007
345 PRE-EXISTING CONDITION IMPROVED 4 0.0006
346 HAEMORRHAGIC STROKE 5 0.0006
347 MEGACOLON 1 0.0006
348 POLYMYALGIA RHEUMATICA 2 0.0006
349 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
350 ENTERITIS 4 0.0006
351 GASTROINTESTINAL TOXICITY 3 0.0006
352 ENTEROCOCCAL INFECTION 3 0.0006
353 MYOCARDITIS 7 0.0006
354 NEOPLASM 7 0.0006
355 HYPERVOLAEMIA 3 0.0006
356 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
357 RESUSCITATION 1 0.0006
358 HYPERNATRAEMIA 3 0.0006
359 MITRAL VALVE PROLAPSE 1 0.0006
360 PYREXIA 206 0.0006
361 TONSILLAR HYPERTROPHY 1 0.0006
362 KLEBSIELLA INFECTION 3 0.0006
363 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
364 CEREBELLAR INFARCTION 1 0.0006
365 ARRHYTHMIA 28 0.0006
366 PLATELET COUNT DECREASED 63 0.0006
367 TOOTH ABSCESS 6 0.0006
368 ENTERITIS INFECTIOUS 1 0.0006
369 ENDOCARDITIS 3 0.0006
370 SKIN NECROSIS 3 0.0006
371 HYPERAMMONAEMIC ENCEPHALOPATHY 1 0.0006
372 COMPRESSION FRACTURE 3 0.0006
373 RECTAL HAEMORRHAGE 24 0.0006
374 PNEUMOMEDIASTINUM 1 0.0006
375 HYDROCEPHALUS 3 0.0006
376 SOFT TISSUE INFECTION 1 0.0005
377 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
378 NECROSIS 3 0.0005
379 ERYTHEMA MULTIFORME 5 0.0005
380 BLOOD IRON INCREASED 1 0.0005
381 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
382 LIP DISORDER 1 0.0005
383 PERONEAL NERVE PALSY 3 0.0005
384 BONE MARROW TRANSPLANT 1 0.0005
385 HYPERTHERMIA 4 0.0005
386 HERPES VIRUS INFECTION 3 0.0005
387 CHOLESTASIS 10 0.0005
388 PULMONARY OEDEMA 23 0.0005
389 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
390 HAEMOPTYSIS 14 0.0005
391 COLITIS 19 0.0005
392 NEUTROPENIA 68 0.0005
393 EPISTAXIS 37 0.0005
394 DERMATITIS ACNEIFORM 3 0.0005
395 THROMBOCYTOPENIA 55 0.0005
396 RECURRENT CANCER 2 0.0005
397 PERIPHERAL ISCHAEMIA 2 0.0005
398 DIVERTICULAR PERFORATION 1 0.0005
399 VENOUS THROMBOSIS LIMB 1 0.0005
400 PSYCHOTIC SYMPTOM 1 0.0005
401 PETECHIAE 5 0.0005
402 STOMATITIS 29 0.0005
403 LUNG ABSCESS 1 0.0005
404 HALLUCINATIONS, MIXED 2 0.0005
405 URINARY BLADDER HAEMORRHAGE 1 0.0005
406 PSEUDOMONAS INFECTION 4 0.0005
407 PNEUMONIA 151 0.0005
408 PERICARDIAL HAEMORRHAGE 1 0.0005
409 INFECTION 66 0.0005
410 HYPOXIA 16 0.0005
411 CORONAVIRUS INFECTION 3 0.0005
412 ILEUS PARALYTIC 2 0.0004
413 PSEUDOMEMBRANOUS COLITIS 1 0.0004
414 LARGE INTESTINAL OBSTRUCTION 1 0.0004
415 MYOSITIS 4 0.0004
416 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
417 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
418 LICHENOID KERATOSIS 1 0.0004
419 NEPHROTIC SYNDROME 3 0.0004
420 PNEUMONIA BACTERIAL 4 0.0004
421 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
422 METASTATIC MALIGNANT MELANOMA 1 0.0004
423 HAEMANGIOMA 1 0.0004
424 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
425 APHASIA 13 0.0004
426 PERFORMANCE STATUS DECREASED 2 0.0004
427 PLEURAL EFFUSION 26 0.0004
428 RESPIRATORY FAILURE 31 0.0004
429 CHOLECYSTITIS 5 0.0004
430 URINARY RETENTION 14 0.0004
431 DIABETES INSIPIDUS 1 0.0004
432 RASH VESICULAR 2 0.0004
433 GUILLAIN-BARRE SYNDROME 2 0.0004
434 LYMPHADENITIS 1 0.0004
435 TRANSPLANT FAILURE 1 0.0004
436 URINARY TRACT INFECTION BACTERIAL 1 0.0004
437 HAEMORRHAGE URINARY TRACT 1 0.0004
438 ANGLE CLOSURE GLAUCOMA 1 0.0004
439 ILEOSTOMY 1 0.0004
440 CANCER PAIN 1 0.0004
441 PERICARDIAL EFFUSION 9 0.0004
442 PHYSICAL DECONDITIONING 1 0.0004
443 ATRIOVENTRICULAR BLOCK 3 0.0004
444 CARDIAC FAILURE 31 0.0004
445 HEPATITIS TOXIC 1 0.0004
446 TONSILLITIS 2 0.0004
447 FOLLICULITIS 4 0.0004
448 SERUM FERRITIN INCREASED 2 0.0004
449 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
450 STAPHYLOCOCCAL INFECTION 12 0.0004
451 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
452 CHOLECYSTITIS INFECTIVE 1 0.0004
453 MALNUTRITION 4 0.0004
454 ANAL HAEMORRHAGE 1 0.0004
455 PROCTITIS 1 0.0004
456 ENDOTRACHEAL INTUBATION 1 0.0004
457 RENAL TUBULAR DISORDER 1 0.0004
458 SKIN TOXICITY 2 0.0004
459 HAEMATOLOGICAL MALIGNANCY 1 0.0004
460 RASH 152 0.0003
461 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
462 PRODUCT ADMINISTRATION ERROR 7 0.0003
463 STRESS CARDIOMYOPATHY 2 0.0003
464 GASTROINTESTINAL NECROSIS 1 0.0003
465 TOOTH DISCOLOURATION 1 0.0003
466 LUNG INFILTRATION 3 0.0003
467 CARDIOTOXICITY 3 0.0003
468 GASTROINTESTINAL INFECTION 3 0.0003
469 THERAPY NON-RESPONDER 15 0.0003
470 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
471 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
472 PROSTATITIS 1 0.0003
473 PHARYNGITIS 4 0.0003
474 HAEMATURIA 11 0.0003
475 MELAENA 7 0.0003
476 HERPES SIMPLEX 2 0.0003
477 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
478 C-REACTIVE PROTEIN INCREASED 11 0.0003
479 OLIGOHYDRAMNIOS 1 0.0003
480 MENINGITIS 2 0.0003
481 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
482 CANDIDA INFECTION 5 0.0003
483 TONGUE ULCERATION 1 0.0003
484 OEDEMA 16 0.0003
485 NEOPLASM RECURRENCE 1 0.0003
486 HYPOPNOEA 1 0.0003
487 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
488 AORTIC STENOSIS 1 0.0003
489 EAR PRURITUS 1 0.0003
490 PAPULE 2 0.0003
491 NECROTISING FASCIITIS 1 0.0003
492 DEATH 244 0.0003
493 PULMONARY TOXICITY 2 0.0003
494 RETINAL HAEMORRHAGE 2 0.0003
495 CONJUNCTIVAL HYPERAEMIA 1 0.0003
496 MONOCYTE COUNT INCREASED 1 0.0003
497 THROMBOCYTOSIS 1 0.0003
498 AMYLASE INCREASED 1 0.0003
499 HEPATIC FUNCTION ABNORMAL 10 0.0003
500 CHEMOTHERAPY 1 0.0003
501 PROTEINURIA 5 0.0003
502 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
503 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
504 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
505 CARDIOPULMONARY FAILURE 1 0.0003
506 GASTROINTESTINAL INFLAMMATION 2 0.0003
507 DIVERTICULITIS 7 0.0003
508 ATRIAL FLUTTER 2 0.0003
509 AZOTAEMIA 1 0.0003
510 OBSTRUCTION 1 0.0003
511 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
512 HYPERAESTHESIA 2 0.0002
513 ESCHERICHIA INFECTION 2 0.0002
514 ILEUS 3 0.0002
515 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
516 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
517 CARDIAC FAILURE CHRONIC 1 0.0002
518 METASTATIC NEOPLASM 1 0.0002
519 MONOPLEGIA 1 0.0002
520 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
521 BLOOD CREATINE INCREASED 1 0.0002
522 LUNG DISORDER 11 0.0002
523 BLOOD BILIRUBIN INCREASED 6 0.0002
524 UVEITIS 3 0.0002
525 TACHYPNOEA 3 0.0002
526 SHOCK 5 0.0002
527 SKIN REACTION 3 0.0002
528 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
529 LEUKAEMIA 2 0.0002
530 CARDIAC TAMPONADE 1 0.0002
531 PULSE ABSENT 1 0.0002
532 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
533 NON-SMALL CELL LUNG CANCER 1 0.0002
534 HUMERUS FRACTURE 1 0.0002
535 SINUS BRADYCARDIA 2 0.0002
536 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
537 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
538 CORONARY ARTERY STENOSIS 1 0.0002
539 SUBARACHNOID HAEMORRHAGE 2 0.0002
540 PHLEBITIS 1 0.0002
541 FEMORAL NECK FRACTURE 1 0.0002
542 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
543 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
544 PERITONITIS 4 0.0002
545 FAILURE TO THRIVE 1 0.0002
546 PERIORBITAL OEDEMA 1 0.0002
547 VENTRICULAR EXTRASYSTOLES 2 0.0002
548 MALABSORPTION 1 0.0002
549 MOUTH ULCERATION 4 0.0002
550 SUDDEN DEATH 2 0.0002
551 ANAEMIA 36 0.0002
552 BRADYCARDIA 10 0.0002
553 ANAL FISTULA 1 0.0002
554 HALLUCINATION 14 0.0002
555 ATRIAL FIBRILLATION 18 0.0002
556 VENTRICULAR FIBRILLATION 2 0.0002
557 STREPTOCOCCAL INFECTION 1 0.0002
558 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
559 SKIN INFECTION 2 0.0002
560 NEPHROPATHY TOXIC 2 0.0002
561 STATUS EPILEPTICUS 2 0.0002
562 COLECTOMY 1 0.0002
563 CHOLECYSTITIS ACUTE 1 0.0002
564 ACUTE KIDNEY INJURY 27 0.0002
565 MYOCARDIAL ISCHAEMIA 2 0.0002
566 INTENTIONAL DOSE OMISSION 5 0.0002
567 EXERCISE TOLERANCE DECREASED 1 0.0002
568 BLOOD URIC ACID INCREASED 1 0.0002
569 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
570 ASCITES 5 0.0002
571 DEEP VEIN THROMBOSIS 11 0.0002
572 PLEURISY 1 0.0002
573 SYMPTOM RECURRENCE 1 0.0002
574 LOCALISED INFECTION 4 0.0002
575 FOETAL GROWTH RESTRICTION 1 0.0002
576 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
577 CEREBRAL INFARCTION 4 0.0002
578 LARYNGEAL OEDEMA 1 0.0002
579 CHOLANGITIS 1 0.0002
580 OLIGURIA 1 0.0002
581 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
582 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
583 HAEMOGLOBIN ABNORMAL 1 0.0002
584 HEPATITIS ACUTE 1 0.0002
585 PRODUCT PREPARATION ISSUE 1 0.0002
586 ORAL CANDIDIASIS 2 0.0002
587 TOOTH INFECTION 2 0.0002
588 PULMONARY CONGESTION 2 0.0002
589 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
590 COLITIS ISCHAEMIC 1 0.0001
591 PRODUCT LABEL ISSUE 1 0.0001
592 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
593 GINGIVAL BLEEDING 2 0.0001
594 FORMICATION 1 0.0001
595 RIGHT VENTRICULAR FAILURE 1 0.0001
596 SINUS TACHYCARDIA 2 0.0001
597 SUBDURAL HAEMATOMA 2 0.0001
598 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
599 OFF LABEL USE 121 0.0001
600 LIVER DISORDER 6 0.0001
601 HEPATOTOXICITY 3 0.0001
602 DUODENAL ULCER PERFORATION 1 0.0001
603 KETOACIDOSIS 1 0.0001
604 CARDIAC ARREST 11 0.0001
605 PEMPHIGOID 1 0.0001
606 TROPONIN INCREASED 1 0.0001
607 LIPASE INCREASED 1 0.0001
608 MUSCULOSKELETAL CHEST PAIN 2 0.0001
609 DECREASED APPETITE 30 0.0001
610 RASH PRURITIC 7 0.0001
611 RENAL DISORDER 6 0.0001
612 HYPOALBUMINAEMIA 1 0.0001
613 NERVOUS SYSTEM DISORDER 4 0.0001
614 PNEUMOTHORAX 2 0.0001
615 COMA 6 0.0001
616 GINGIVAL PAIN 1 0.0001
617 OXYGEN SATURATION DECREASED 7 0.0001
618 INTERSTITIAL LUNG DISEASE 6 0.0001
619 ABNORMAL FAECES 1 0.0001
620 VENTRICULAR TACHYCARDIA 2 0.0001
621 HAEMODIALYSIS 1 0.0001
622 INFUSION SITE ERYTHEMA 1 0.0001
623 HAEMATEMESIS 3 0.0001
624 FACIAL PARALYSIS 1 0.0001
625 SINUSITIS 12 0.0001
626 ANURIA 1 0.0001
627 RASH GENERALISED 3 0.0001
628 CARDIAC MURMUR 1 0.0001
629 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
630 GASTRITIS 3 0.0001
631 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
632 ALOPECIA 22 0.0001
633 HAEMARTHROSIS 1 0.0001
634 ANAL INCONTINENCE 1 0.0001
635 PATHOGEN RESISTANCE 1 0.0001
636 END STAGE RENAL DISEASE 2 0.0001
637 BRAIN NEOPLASM 1 0.0001
638 HAEMATOCHEZIA 6 0.0001
639 UROSEPSIS 1 0.0001
640 CONJUNCTIVITIS 2 0.0001
641 AGRANULOCYTOSIS 2 0.0001
642 BLOOD CREATININE INCREASED 7 0.0001
643 HAEMOGLOBIN DECREASED 11 0.0001
644 NEPHROPATHY 1 0.0001
645 APPENDICITIS 1 0.0001
646 ERYTHEMA 22 0.0001
647 SPUTUM DISCOLOURED 1 0.0001
648 HAEMATOTOXICITY 1 0.0001
649 GASTRIC ULCER 2 0.0001
650 RASH ERYTHEMATOUS 5 0.0001
651 AFFECT LABILITY 1 0.0001
652 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
653 CHEST PAIN 19 0.0001
654 CHOKING 2 0.0001
655 ORAL HERPES 2 0.0001
656 PHARYNGEAL SWELLING 1 0.0001
657 RENAL TUBULAR NECROSIS 1 0.0001
658 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
659 HEPATOMEGALY 1 0.0001
660 BRAIN INJURY 1 0.0001
661 HYPOTHERMIA 1 0.0001
662 TASTE DISORDER 2 0.0001
663 MOTOR DYSFUNCTION 1 0.0001
664 NEUTROPHIL COUNT INCREASED 1 0.0001
665 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
666 PULMONARY HYPERTENSION 2 0.0001
667 HAEMORRHAGE 10 0.0001
668 DERMATITIS 2 0.0001
669 FULL BLOOD COUNT ABNORMAL 1 0.0001
670 HYPERTENSION 20 0.0001
671 FAECES DISCOLOURED 2 0.0001
672 SKIN LACERATION 1 0.0001
673 COVID-19 16 0.0001
674 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
675 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
676 TACHYCARDIA 8 0.0001
677 TRANSAMINASES INCREASED 2 0.0001
678 HYPERTENSIVE CRISIS 1 0.0001
679 RASH PAPULAR 2 0.0001
680 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
681 INTESTINAL PERFORATION 1 0.0001
682 FISTULA 1 0.0001
683 BLOOD CALCIUM DECREASED 1 0.0001
684 GASTRIC HAEMORRHAGE 1 0.0001
685 METASTASES TO LUNG 1 0.0001
686 DELIRIUM 3 0.0001
687 POST PROCEDURAL HAEMORRHAGE 1 0.0001
688 VASCULITIS 1 0.0001
689 BLADDER CANCER 5 0.0001
690 COVID-19 PNEUMONIA 1 0.0001
691 ATAXIA 1 0.0001
692 DISEASE RECURRENCE 4 0.0001
693 ACCIDENT 1 0.0001
694 URTICARIA 14 0.0001
695 DRUG INTOLERANCE 8 0.0001
696 PRESYNCOPE 2 0.0001
697 DYSURIA 3 0.0001
698 ENCEPHALOPATHY 2 0.0001
699 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
700 PNEUMONIA ASPIRATION 2 0.0001
701 INTESTINAL OBSTRUCTION 3 0.0001
702 DERMATITIS ALLERGIC 1 0.0001
703 FLUID RETENTION 4 0.0001
704 DRUG RESISTANCE 2 0.0001
705 SKIN ULCER 2 0.0001
706 RESPIRATORY TRACT INFECTION 2 0.0001
707 PLATELET COUNT INCREASED 1 0.0001
708 NODULE 1 0.0001
709 PANCREATITIS 4 0.0001
710 CARDIAC FAILURE CONGESTIVE 6 0.0001
711 PNEUMONITIS 2 0.0001
712 SKIN LESION 2 0.0001
713 MENTAL STATUS CHANGES 2 0.0001
714 RHABDOMYOLYSIS 3 0.0001
715 NO ADVERSE EVENT 13 0.0001
716 CARDIO-RESPIRATORY ARREST 3 0.0001
717 LYMPHOPENIA 1 0.0001
718 DIARRHOEA 45 0.0001
719 SEIZURE 8 0.0001
720 VAGINAL HAEMORRHAGE 3 0.0001
721 CONSTIPATION 15 0.0001
722 FLUID OVERLOAD 1 0.0001
723 BONE PAIN 4 0.0001
724 ACUTE MYOCARDIAL INFARCTION 2 0.0001
725 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
726 SKIN HAEMORRHAGE 1 0.0001
727 PULMONARY MASS 1 0.0001
728 COLON CANCER 1 0.0001
729 RESPIRATORY DISORDER 2 0.0001
730 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
731 BLOOD COUNT ABNORMAL 1 0.0001
732 HYPOKALAEMIA 3 0.0001
733 THERAPY PARTIAL RESPONDER 1 0.0001
734 NEUROPATHY PERIPHERAL 6 0.0001
735 ULCER 1 0.0001
736 MUSCLE TIGHTNESS 1 0.0001
737 MANIA 1 0.0001
738 BACK PAIN 14 0.0001
739 RENAL FAILURE 8 0.0001
740 EXPIRED PRODUCT ADMINISTERED 2 0.0001
741 CYTOMEGALOVIRUS INFECTION 1 0.0001
742 COAGULOPATHY 1 0.0001
743 LEUKOPENIA 3 0.0001
744 BLOOD UREA INCREASED 1 0.0001
745 RENAL IMPAIRMENT 5 0.0001
746 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
747 HEMIPARESIS 1 0.0001
748 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
749 DRUG INEFFECTIVE 76 0.0001
750 ORTHOSTATIC HYPOTENSION 1 0.0001
751 ECZEMA 3 0.0001
752 PRODUCT STORAGE ERROR 5 0.0001
753 HEART RATE DECREASED 2 0.0001
754 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
755 HEAD DISCOMFORT 1 0.0001
756 ISCHAEMIC STROKE 1 0.0001
757 GALLBLADDER DISORDER 1 0.0001
758 LEUKOCYTOSIS 1 0.0001
759 TOOTHACHE 1 0.0001
760 OSTEOMYELITIS 1 0.0001
761 ADVERSE EVENT 5 0.0001
762 SWELLING 5 0.0001
763 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
764 NAUSEA 42 0.0001
765 PULMONARY FIBROSIS 1 0.0001
766 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
767 HOSPITALISATION 8 0.0001
768 EAR PAIN 1 0.0001
769 SKIN FISSURES 1 0.0001
770 DISABILITY 1 0.0001
771 BLOOD PRESSURE ABNORMAL 1 0.0001
772 HYPOTENSION 10 0.0000
773 THROMBOSIS 4 0.0000
774 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
775 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
776 OEDEMA PERIPHERAL 6 0.0000
777 BLINDNESS 2 0.0000
778 BODY TEMPERATURE INCREASED 1 0.0000
779 PRODUCT PREPARATION ERROR 1 0.0000
780 LUNG NEOPLASM MALIGNANT 2 0.0000
781 ABDOMINAL PAIN 11 0.0000
782 SKIN CANCER 1 0.0000
783 BALANCE DISORDER 4 0.0000
784 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
785 PRODUCT PRESCRIBING ISSUE 1 0.0000
786 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
787 BLOOD PRESSURE DECREASED 3 0.0000
788 STEVENS-JOHNSON SYNDROME 1 0.0000
789 ORAL PAIN 1 0.0000
790 CHROMATURIA 1 0.0000
791 HEPATIC ENZYME INCREASED 3 0.0000
792 SKIN DISCOLOURATION 2 0.0000
793 PRODUCT USE ISSUE 8 0.0000
794 PRODUCT PRESCRIBING ERROR 1 0.0000
795 MENTAL IMPAIRMENT 1 0.0000
796 LIVER INJURY 1 0.0000
797 WEIGHT INCREASED 9 0.0000
798 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
799 INFLAMMATION 2 0.0000
800 HAEMATOMA 1 0.0000
801 PALLOR 1 0.0000
802 TREATMENT NONCOMPLIANCE 2 0.0000
803 RESPIRATORY DISTRESS 1 0.0000
804 ANAPHYLACTIC REACTION 2 0.0000
805 CONDITION AGGRAVATED 11 0.0000
806 DEMENTIA 1 0.0000
807 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
808 URINARY TRACT INFECTION 6 0.0000
809 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
810 LIVER FUNCTION TEST ABNORMAL 1 0.0000
811 DYSSTASIA 1 0.0000
812 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
813 URINARY INCONTINENCE 1 0.0000
814 HEPATIC FAILURE 1 0.0000
815 EPILEPSY 1 0.0000
816 INJECTION SITE RASH 1 0.0000
817 OROPHARYNGEAL PAIN 3 0.0000
818 CARDIAC DISORDER 3 0.0000
819 METABOLIC ACIDOSIS 1 0.0000
820 LACTIC ACIDOSIS 1 0.0000
821 SWELLING FACE 2 0.0000
822 OSTEONECROSIS 1 0.0000
823 INFUSION RELATED REACTION 2 0.0000
824 SKIN DISORDER 1 0.0000
825 VOMITING 14 0.0000
826 MALAISE 13 0.0000
827 RASH MACULAR 1 0.0000
828 LYMPHADENOPATHY 1 0.0000
829 HYPERGLYCAEMIA 1 0.0000
830 RESTLESSNESS 1 0.0000
831 DYSGEUSIA 2 0.0000
832 INFLUENZA 3 0.0000
833 EYE SWELLING 1 0.0000
834 DYSARTHRIA 1 0.0000
835 UNEVALUABLE EVENT 2 0.0000
836 ARTHRITIS 2 0.0000
837 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
838 COUGH 7 0.0000
839 TREATMENT FAILURE 2 0.0000
840 FALL 8 0.0000
841 CEREBROVASCULAR ACCIDENT 4 0.0000
842 MYOCARDIAL INFARCTION 4 0.0000
843 ADVERSE DRUG REACTION 2 0.0000
844 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
845 TINNITUS 1 0.0000
846 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
847 HYPERSENSITIVITY 4 0.0000
848 COGNITIVE DISORDER 1 0.0000
849 PULMONARY EMBOLISM 2 0.0000
850 HYPOAESTHESIA 3 0.0000
851 SYNCOPE 2 0.0000
852 ASTHENIA 7 0.0000
853 MEDICATION ERROR 1 0.0000
854 HYPONATRAEMIA 1 0.0000
855 EYE PAIN 1 0.0000
856 MUSCULAR WEAKNESS 2 0.0000
857 HERPES ZOSTER 1 0.0000
858 DYSPHONIA 1 0.0000
859 IRRITABILITY 1 0.0000
860 FEELING HOT 1 0.0000
861 VISUAL IMPAIRMENT 2 0.0000
862 PRURITUS 6 0.0000
863 RHINORRHOEA 1 0.0000
864 ABDOMINAL PAIN UPPER 3 0.0000
865 HEADACHE 9 0.0000
866 INJURY 1 0.0000
867 DYSPNOEA 8 0.0000
868 UNDERDOSE 1 0.0000
869 AGITATION 1 0.0000
870 DIABETES MELLITUS 1 0.0000
871 PERIPHERAL SWELLING 2 0.0000
872 SKIN EXFOLIATION 1 0.0000
873 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
874 GASTROINTESTINAL DISORDER 1 0.0000
875 BREAST CANCER 1 0.0000
876 FLUSHING 1 0.0000
877 PAIN 6 0.0000
878 FATIGUE 7 0.0000
879 CHILLS 1 0.0000
880 JOINT SWELLING 1 0.0000
881 LOSS OF CONSCIOUSNESS 1 0.0000
882 PSORIASIS 1 0.0000
883 DEHYDRATION 1 0.0000
884 DRY SKIN 1 0.0000
885 PAIN IN EXTREMITY 2 0.0000
886 BLOOD PRESSURE INCREASED 1 0.0000
887 DRUG INTERACTION 1 0.0000
888 CONFUSIONAL STATE 1 0.0000
889 DRUG DOSE OMISSION 1 0.0000
890 MYALGIA 1 0.0000
891 BLOOD GLUCOSE INCREASED 1 0.0000
892 GAIT DISTURBANCE 1 0.0000
893 SOMNOLENCE 1 0.0000
894 ARTHRALGIA 2 0.0000
895 INCORRECT DOSE ADMINISTERED 1 0.0000
896 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
897 WEIGHT DECREASED 1 0.0000
898 ANXIETY 1 0.0000